In line with these findings, gelatin zymography studies showed increased MMP-9 activity, but not MMP-2, in brains affected by AD and mild cognitive impairment (Lorenzl et al., 2007; Bruno et al., 2009). Here, MMP9 is linked to Alzheimer disease.